Nutrition plays a crucial role in the lives of people with cancer. But more than a million people suffering from the disease in the United States also endure a wasting syndrome called cachexia.

Researchers from Canada’s McGill University have developed a potential tool that can detect early signs of cachexia in cancer patients, which could impact survival. Cancer cachexia is a phenomenon ...

Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...

Until recently, the root cause of cachexia was identified as the inflammatory mediators produced either by the tumour itself ...

One of the most pernicious conditions that arises as a consequence of cancer is a sort of wasting syndrome. More formally known as cachexia, it causes patients to lose body mass (including both muscle ...

Cancer-associated cachexia is a multifactorial wasting disorder characterized by anorexia, unintentional weight loss (WL, skeletal muscle mass with or without loss of fat mass), progressive functional ...

DelveInsight’s ‘Cancer Cachexia Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Cancer Cachexia epidemiology in the 7MM, i.e., the ...

Maintaining good health and well-being is crucial for how well patients respond to cancer treatments. Unfortunately, cachexia, or involuntary weight loss, is a major concern for many individuals with ...

The AHA released a statement for malnutrition and cachexia in patients with cardiac conditions, and discuss clinical strategies for support and management.

A nationwide clinical trial shows positive results for cancer patients with this common wasting syndrome. Researchers discovered a drug that safely and effectively helped cancer patients when they ...

Many important advances have occurred in the field of cancer cachexia over the past decade, including progress in understanding the mechanisms of CACS and the development of promising pharmacologic ...